Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: CA Cancer J Clin. 2022 Aug 2;73(1):72–112. doi: 10.3322/caac.21752

Table 1:

TNM staging of sinonasal malignancies as per AJCC 8th edition

TNM Staging Nasal cavity/Ethmoid Sinus Maxillary Sinus
T-stage
Tis Carcinoma in situ
T1 tumor limited to one subsite (septum, floor, lateral wall, or vestibule (edge of naris to mucocutaneous junction of nasal cavity); left or right ethmoid sinus) tumor limited to maxillary sinus mucosa (no bone erosion/destruction)
T2 tumor involving two subsites in one region or extending to involve an adjacent region in the nasoethmoidal complex tumor with bone erosion/destruction, including extension into hard palate and/or middle meatus, excluding structures in a higher T category
T3 Tumor invades any of the following:
 • medial wall or floor of orbit
 • maxillary sinus
 • palate
 • cribriform plate
Tumor invades any of the following:
 • bone of posterior wall of maxillary sinus
 • subcutaneous tissues
 • floor or medial wall of orbit
 • pterygoid fossa
 • ethmoid sinuses
T4a Tumor invades any of the following:
 • anterior orbital contents
 • skin of nose or cheek
 • minimal extension to anterior cranial fossa
 • pterygoid plates
 • Sphenoid sinus
 • Frontal sinus
Tumor invades any of the following:
 • anterior orbital contents
 • skin of cheek
 • pterygoid plates
 • infratemporal fossa
 • cribriform plate
 • sphenoid sinus
 • frontal sinus
T4b Tumor invades any of the following:
 • orbital apex
 • middle cranial fossa
 • dura
 • brain
 • cranial nerves other than maxillary division of trigeminal nerve (V2)
 • nasopharynx
 • clivus
N-stage
N0 no regional node metastases
N1 metastasis in single ipsilateral node, ≤3 cm, and no extranodal extension (ENE(−))
N2a metastasis in single ipsilateral node, >3 cm and ≤6 cm, and ENE(−); or metastasis in single ipsilateral node, ≤3 cm, and ENE(+)
N2b metastasis in multiple ipsilateral nodes, all ≤6 cm, and ENE(−)
N2c metastasis in bilateral or contralateral nodes, all ≤6 cm, and ENE(−)
N3a metastasis in a node, >6 cm, and ENE(−)
N3b metastasis in single ipsilateral node, >3 cm, and ENE(+); or multiple ipsilateral, contralateral, or bilateral nodes any with ENE(+); or single contralateral node of any size and ENE(+)